149 filings
Page 3 of 8
8-K
yhs0j4h
18 Oct 21
ESPERION Announces Plan for Transformative Long-Term Growth
7:30am
8-K
ux770ohmuffazzk7doz3
3 Aug 21
ESPERION Reports Second Quarter 2021 Financial Results and Provides Company Update
7:12am
8-K
zgctqk z87oaomgw
28 Jun 21
ESPERION Appoints JoAnne Micale Foody, MD, FACC, FAHA as Chief Medical Officer
4:03pm
8-K
axy2anvc78hktjmk3a
28 May 21
Submission of Matters to a Vote of Security Holders
4:04pm
8-K
o6gsipzxwi
17 May 21
ESPERION Appoints Sheldon Koenig as President and CEO
9:09am
8-K
1j24mokb3fo5l
4 May 21
ESPERION Reports First Quarter 2021 Financial Results and Provides Company Update
4:10pm
8-K
b9qi4n9
26 Apr 21
Esperion Expands Partnership with Daiichi Sankyo Group to Additional Territories
5:00pm
8-K
lk3ux7j db
23 Feb 21
ESPERION Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Company Update
4:15pm
8-K
1epwwepzflwa8
13 Jan 21
ESPERION Reports Preliminary Fourth Quarter 2020 Financial Results and Further Commits to Unmet Patient Needs with Oral PCSK9 Inhibitor Program
7:00am
8-K
dykl 6xv03dj
16 Dec 20
Other Events
7:36am
8-K
q4q5rr
15 Dec 20
ESPERION Appoints Sheldon Koenig as Chief Operating Officer
7:32am
8-K
jyvfiu0 5sfbp
16 Nov 20
Entry into a Material Definitive Agreement
5:15pm
8-K
e7dz4h12wq a7dre1
12 Nov 20
Esperion Announces Private Offering of $200.0 Million of Convertible Senior Subordinated Notes
7:01am
8-K
ezm4pl6gi8
2 Nov 20
ESPERION Reports Third Quarter 2020 Financial Results and Provides Company Update
4:28pm
8-K
nxlmfvmjx9v
10 Aug 20
Esperion Reports Second Quarter 2020 Financial Results and Provides Company Update
4:15pm
8-K
m3a lob5o
22 Jun 20
Esperion and Daiichi Sankyo Europe Announce Amendment to License and Commercial Collaboration Agreement
8:00am
8-K
aw3xhngof8adhsn08
29 May 20
Departure of Directors or Certain Officers
4:32pm
8-K
38jcaesbpdpt7l
6 May 20
Esperion Reports First Quarter 2020 Financial Results and Provides Company Update
4:16pm
8-K
duh9xcm
20 Apr 20
Entry into a Material Definitive Agreement
8:01am
8-K
xtdrl9uj9a5s qssrz
9 Apr 20
Regulation FD Disclosure
10:34am